A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Neurology Minute · American Academy of Neurology
July 31, 20252m 15s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.
Show reference: